Why it matters: Alexandria Ocasio-Cortez (AOC), a Democratic Representative, has expressed concerns about President Joe Biden’s approach to cannabis and psychedelics. She believes that Biden’s regressive stance on cannabis policy may also affect his approach to other drugs. This raises questions about the Biden administration’s commitment to addressing the changing public opinions on psychedelics.
What they are saying: AOC argues that Biden’s past comments on marijuana, such as calling it a “gateway drug,” indicate a lack of evidence-based understanding and suggest a regressive approach. She also highlights the dismissive reaction from a senior member of her party when she introduced pro-psychedelic legislation. AOC and others have been pushing for increased access to psychedelic treatments for veterans and active-duty service members.
The big picture: Cannabis and psychedelics are gaining acceptance among the American public, and recent developments, such as Biden’s pardon of federal cannabis convictions and the FDA issuing clinical trial guidelines for psychedelics, suggest progress in drug policy reform. However, AOC’s concerns about Biden’s stance and the reaction from lawmakers reflect a potential obstacle to further advancements in addressing psychedelics.
What to watch: It will be important to monitor the Biden administration’s actions and statements regarding cannabis and psychedelics. If Biden continues to support progressive drug policies and initiatives, it could signal a shift in the Democratic Party’s approach. Additionally, the reactions and support from other lawmakers will be indicative of the broader political landscape surrounding drug policy.
My take: AOC raises valid concerns about President Biden’s previous stance on cannabis and the potential implications for his approach to psychedelics. While recent developments suggest some progress, it remains to be seen how committed the Biden administration is to embracing the changing public opinions on these substances. The reactions from other lawmakers highlight the challenges faced in advancing drug policy reform. Overall, continued advocacy and pressure from lawmakers like AOC will be crucial in pushing for a more progressive approach to psychedelics.
